Furthermore, there were significant associations between BRCA1 promoter methylation and clinicopathological characteristics in breast tumors, such as lymph node metastasis, high histological grade, ER-negative, PR-negative, triple-negative phenotype and reduced or lack expression of BRCA1 protein. Here, ESR1 is linked to breast neoplasm.